Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

探索与服务
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
法律与隐私
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
  1. 首页
  2. 新闻
  3. STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

STAT News

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.

前往出版商网站继续阅读完整报道。

在 STAT News 阅读全文
S

作者 STAT News

8 September 2026|1 分钟阅读
分享
Health Tech
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
分享
← 返回 IE News

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

  • STAT+: FDA names acting heads of drug and vaccine centers to permanent roles

    STAT News

    STAT+: FDA names acting heads of drug and vaccine centers to permanent roles

    8 September 2026
  • STAT+: FDA approves AstraZeneca breast cancer drug

    STAT News

    STAT+: FDA approves AstraZeneca breast cancer drug

    8 September 2026
  • STAT+: FDA takes another look at botanical drugs

    STAT News

    STAT+: FDA takes another look at botanical drugs

    4 September 2026
  • An administrative gap delays access to new pancreatic cancer treatment

    STAT News

    An administrative gap delays access to new pancreatic cancer treatment

    8 September 2026
  • STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    STAT News

    STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

    4 September 2026
  • Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    STAT News

    Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    4 September 2026

相关洞察

  • Future Supply Chains, Logistics & Fleets

    The Supply Chain That Thinks - How AI agents, quantum computing, cheap energy and programmable risk could reshape global logistics, 2026–2036

    9 Sept 202619 min read
  • Synthetic biology and bioengineering

    The Bio Revolution Is Here — And the World Is Already Choosing Sides

    Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.

    8 Sept 202615 min read
  • Quantum computing

    The race to master quantum computing could reshape medicine, energy and security.

    8 Sept 202623 min read
Browse all insights →

相关活动

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • Autonomous e-Mobility Forum 2026

    7 Sept 2026
    Qatar
  • Saudi Warehousing & Logistics Expo 2026

    8 Sept 2026
    Riyadh, Saudi Arabia
  • FIBO Arabia 2026

    8 Sept 2026
    Riyadh, Saudi Arabia
浏览所有活动→

更多新闻中心内容

  • STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting

    STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting

    7 September 2026
  • Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more

    Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more

    5 September 2026
  • STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

    STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

    8 September 2026
  • STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

    STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

    4 September 2026
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

探索与服务
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
法律与隐私
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF103.4.